Quality & Outcomes: Ventricular Tachycardia Procedures
In 2012, the HUP EP team performed 277 ablations for ventricular tachycardia including 42 epicardial ablation procedures, and received patient referrals from across the United States for the treatment of VT.
VT Ablation Case Volumes at HUP FY 2004 - FY 2012, N = 2332
Surgical Treatment of Ventricular Tachycardia
Penn electrophysiologists and surgeons are defining new roles for surgery in the treatment of cardiovascular arrhythmias. Detailed mapping allows the precise placement of cryoablation lesions in the OR in patients with VT and nonischemic cardiomyopathy.
Nonsurgical Approaches to VT
Identifying Epicardial Ventricular Tachycardia in Nonischemic Cardiomyopathy
HUP's EP team uses a percutaneous nonsurgical approach that targets the epicardium to eliminate VT associated with nonischemic cardiomyopathy of the right and left ventricles in patients experiencing multiple shocks from their ICDs for recurrences of VT. Without VT control, heart transplantation is frequently the only option remaining for these patients.
Preventing Sudden Death and Advancing Treatment of Ventricular Tachycardia
Penn is a national leader in VT ablation procedures. Electrophysiologists from the Hospital of the University of Pennsylvania pioneered substrate-based catheter ablation to treat unmappable ventricular tachycardias, as well as the use of intracardiac echo to facilitate mapping and ablation of a variety of rhythm disorders.
Penn Heart & Vascular Clinical Activity Reports
Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.